UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011218
Receipt number R000011698
Scientific Title The effectiveness of Cholestimide on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial
Date of disclosure of the study information 2013/07/18
Last modified on 2014/01/27 12:13:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness of Cholestimide
on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Acronym

The effectiveness of Cholestimide
on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Scientific Title

The effectiveness of Cholestimide
on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Scientific Title:Acronym

The effectiveness of Cholestimide
on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Region

Japan


Condition

Condition

Type 2 Diabetes, Dyslipidemia

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effectiveness of cholestimide on visceral fat, basal metablic rate and blood glucose in type 2 Diabetes, dyslipidemia patients with visceral fat accumulation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Visceral fat area

Key secondary outcomes

1. Resting energy expenditure, Respiratory quotient
2. HbA1c, blood glucose, Insulin secretion
3.lipid metabolism
4.oxidative stress


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of Cholestimide 3g/day add on to statin for the first 24 weeks, then withdrawal of Cholestimide for the next 24 weeks

Interventions/Control_2

Administration of statin for the first 24 weeks, then add Cholestimide 3g/day for the next 24 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients whose body mass index(BMI) is above 25, Visceral fat area is above 100cm2, andHbA1c(NGSP) is above 6.5%
Patients who have dyslipidemia and administered by Atorvastatin , Pitavastatin or Rosuvastation at least for 2 months, and LDL-cholesterol is above 90 mg/dl

Key exclusion criteria

Patients with complete biliary obstruction
Patients with hypersensitivity to cholestimide or past history of ileus.
Patients with poor control of constipation
Patients who take warfarin, tetracycline, Phenobarbital, thyroid gland preparation, digitalis
Patients with unstable proliferative diabetic retinopathy
Patients whose stage of diabetic nephropathy is above stage 4
Patients who have active infection or are under treatment of malignancy
Patients who have macroangiopathy
Patients who are considered to be inadequate to participate in this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuko Uchigata

Organization

Tokyo Women's Medical University

Division name

Diabetes Center

Zip code


Address

8-1 Kawadacho, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Email

uchigata@dmc.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Risa Ide

Organization

Tokyo Women's Medical University

Division name

Diabetes Center

Zip code


Address

8-1 Kawadacho, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Homepage URL


Email

fujimaki@dmc.twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University, Diabetes Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 12 Month 18 Day

Date of IRB


Anticipated trial start date

2008 Year 05 Month 01 Day

Last follow-up date

2013 Year 09 Month 07 Day

Date of closure to data entry

2013 Year 10 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 07 Month 18 Day

Last modified on

2014 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011698


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name